fentanyl has been researched along with Metastase in 16 studies
Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We prospectively investigated the reduced effects of adverse events caused by sustained-release oral morphine and controlled-release oxycodone after rotating to the fentanyl patch in patients with metastatic breast cancer." | 9.16 | [A pilot study of the reduced effects of adverse events caused by oral morphine and oxycodone after rotating to fentanyl patch in patients with metastatic breast cancer]. ( Fujii, S; Ikeda, M; Koike, Y; Kubo, S; Kurebayashi, J; Mizutou, A; Nakashima, K; Nomura, T; Oota, Y; Saitou, W; Seki, M; Shiiki, S; Shimo, T; Sonoo, H; Tanaka, K; Yamamoto, Y; Yamashita, T, 2012) |
| "The aim of this observational study was to examine pain management outcomes and quality of life (QoL) measures in cancer patients with intolerable or chronic severe pain transferring from World Health Organization's step I, II, and III analgesics to the transdermal therapeutic fentanyl system (TTS-F)." | 9.11 | Pain management of cancer patients with transdermal fentanyl: a study of 1828 step I, II, & III transfers. ( Georgaki, S; Katsouda, E; Kouloulias, V; Kouvaris, J; Mystakidou, K; Parpa, E; Tsilika, E; Vlahos, L, 2004) |
| "This exploratory study shows that IV Fentanyl can alleviate dyspnea in some patients but is an example of the difficulties conducting dyspnea research." | 7.83 | Intravenous Fentanyl for Dyspnea at the End of Life: Lessons for Future Research in Dyspnea. ( Pang, GS; Qu, LM; Tan, YY; Yee, AC, 2016) |
| " The bioavailability of fentanyl was statistically different according to patient age." | 5.33 | Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients. ( Astre, C; Bressolle, F; Caumette, L; Coulouma, R; Culine, S; Garcia, F; Pinguet, F; Solassol, I; Thézenas, S, 2005) |
| "We prospectively investigated the reduced effects of adverse events caused by sustained-release oral morphine and controlled-release oxycodone after rotating to the fentanyl patch in patients with metastatic breast cancer." | 5.16 | [A pilot study of the reduced effects of adverse events caused by oral morphine and oxycodone after rotating to fentanyl patch in patients with metastatic breast cancer]. ( Fujii, S; Ikeda, M; Koike, Y; Kubo, S; Kurebayashi, J; Mizutou, A; Nakashima, K; Nomura, T; Oota, Y; Saitou, W; Seki, M; Shiiki, S; Shimo, T; Sonoo, H; Tanaka, K; Yamamoto, Y; Yamashita, T, 2012) |
| "The aim of this observational study was to examine pain management outcomes and quality of life (QoL) measures in cancer patients with intolerable or chronic severe pain transferring from World Health Organization's step I, II, and III analgesics to the transdermal therapeutic fentanyl system (TTS-F)." | 5.11 | Pain management of cancer patients with transdermal fentanyl: a study of 1828 step I, II, & III transfers. ( Georgaki, S; Katsouda, E; Kouloulias, V; Kouvaris, J; Mystakidou, K; Parpa, E; Tsilika, E; Vlahos, L, 2004) |
| "This exploratory study shows that IV Fentanyl can alleviate dyspnea in some patients but is an example of the difficulties conducting dyspnea research." | 3.83 | Intravenous Fentanyl for Dyspnea at the End of Life: Lessons for Future Research in Dyspnea. ( Pang, GS; Qu, LM; Tan, YY; Yee, AC, 2016) |
| "Treatment directed towards painful metastases must be considered." | 2.66 | Breakthrough cancer pain in 2020. ( Klepstad, P; Løhre, ET; Thronæs, M, 2020) |
| "Buprenorphine (0." | 1.34 | Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment. ( Franchi, S; Panerai, AE; Sacerdote, P, 2007) |
| " The bioavailability of fentanyl was statistically different according to patient age." | 1.33 | Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients. ( Astre, C; Bressolle, F; Caumette, L; Coulouma, R; Culine, S; Garcia, F; Pinguet, F; Solassol, I; Thézenas, S, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Løhre, ET | 1 |
| Thronæs, M | 1 |
| Klepstad, P | 1 |
| Yousef, AA | 1 |
| Alzeftawy, AE | 1 |
| Pang, GS | 1 |
| Qu, LM | 1 |
| Tan, YY | 1 |
| Yee, AC | 1 |
| Rousseau, P | 1 |
| Ikeda, M | 1 |
| Sonoo, H | 1 |
| Kurebayashi, J | 1 |
| Oota, Y | 1 |
| Fujii, S | 1 |
| Shimo, T | 1 |
| Mizutou, A | 1 |
| Seki, M | 1 |
| Saitou, W | 1 |
| Yamashita, T | 1 |
| Koike, Y | 1 |
| Yamamoto, Y | 1 |
| Shiiki, S | 1 |
| Nakashima, K | 1 |
| Tanaka, K | 1 |
| Nomura, T | 1 |
| Kubo, S | 1 |
| Juba, KM | 1 |
| Wahler, RG | 1 |
| Daron, SM | 1 |
| Page, GG | 1 |
| Mystakidou, K | 1 |
| Parpa, E | 1 |
| Tsilika, E | 1 |
| Katsouda, E | 1 |
| Kouloulias, V | 1 |
| Kouvaris, J | 1 |
| Georgaki, S | 1 |
| Vlahos, L | 1 |
| Shavit, Y | 1 |
| Ben-Eliyahu, S | 1 |
| Zeidel, A | 1 |
| Beilin, B | 1 |
| Solassol, I | 1 |
| Caumette, L | 1 |
| Bressolle, F | 1 |
| Garcia, F | 1 |
| Thézenas, S | 1 |
| Astre, C | 1 |
| Culine, S | 1 |
| Coulouma, R | 1 |
| Pinguet, F | 1 |
| Franchi, S | 1 |
| Panerai, AE | 1 |
| Sacerdote, P | 1 |
| Lees, DE | 1 |
| Kim, YD | 1 |
| Bull, JM | 1 |
| Whang-Peng, J | 1 |
| Schuette, W | 1 |
| Smith, R | 1 |
| Macnamara, TE | 1 |
| Zenz, M | 2 |
| Donner, B | 2 |
| Strumpf, M | 1 |
| Lautraite, C | 1 |
| André, N | 1 |
| Portas, M | 1 |
| Bernard, JL | 1 |
| Jennett, WB | 1 |
| Barker, J | 1 |
| Fitch, W | 1 |
| McDowall, DG | 1 |
2 reviews available for fentanyl and Metastase
| Article | Year |
|---|---|
Breakthrough cancer pain in 2020.
Topics: Analgesics, Opioid; Breakthrough Pain; Cancer Pain; Fentanyl; Humans; Neoplasm Metastasis; Pain Mana | 2020 |
The immune-suppressive effects of pain.
Topics: Analgesics, Opioid; Animals; Bupivacaine; Cyclooxygenase Inhibitors; Fentanyl; Humans; Immune Tolera | 2003 |
5 trials available for fentanyl and Metastase
| Article | Year |
|---|---|
The efficacy of oral piroxicam fast-dissolving tablets versus sublingual fentanyl in incident breakthrough pain due to bone metastases: a double-blinded randomized study.
Topics: Administration, Sublingual; Anti-Inflammatory Agents, Non-Steroidal; Bone Neoplasms; Breakthrough Pa | 2019 |
[A pilot study of the reduced effects of adverse events caused by oral morphine and oxycodone after rotating to fentanyl patch in patients with metastatic breast cancer].
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Breast Neoplasms; Drug Therapy, Combin | 2012 |
Pain management of cancer patients with transdermal fentanyl: a study of 1828 step I, II, & III transfers.
Topics: Administration, Cutaneous; Adult; Aged; Analgesics, Opioid; Female; Fentanyl; Follow-Up Studies; Hum | 2004 |
Transdermal fentanyl: a new step on the therapeutic ladder.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Aged, 80 and over; Ambulatory Care; Bl | 1995 |
Effect of anaesthesia on intracranial pressure in patients with space-occupying lesions.
Topics: Adolescent; Adult; Aged; Anesthesia, Endotracheal; Benperidol; Blood Pressure; Blood Volume; Brain A | 1969 |
9 other studies available for fentanyl and Metastase
| Article | Year |
|---|---|
Intravenous Fentanyl for Dyspnea at the End of Life: Lessons for Future Research in Dyspnea.
Topics: Aged; Aged, 80 and over; Analgesics, Opioid; Anxiety; Dyspnea; Female; Fentanyl; Humans; Infusions, | 2016 |
Rocky.
Topics: Analgesics, Opioid; Female; Fentanyl; Humans; Neoplasm Metastasis; Ovarian Neoplasms; Pain; Pain Man | 2012 |
Morphine and hydromorphone-induced hyperalgesia in a hospice patient.
Topics: Adult; Analgesics, Opioid; Carcinoma, Non-Small-Cell Lung; Delayed-Action Preparations; Female; Fent | 2013 |
Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study.
Topics: Adenocarcinoma; Analgesics, Opioid; Animals; Cell Line, Tumor; Disease Models, Animal; Dose-Response | 2004 |
Inter- and intra-individual variability in transdermal fentanyl absorption in cancer pain patients.
Topics: Administration, Cutaneous; Aged; Analgesics, Opioid; Drug Delivery Systems; Female; Fentanyl; Humans | 2005 |
Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment.
Topics: Analgesics, Opioid; Analysis of Variance; Animals; Breast Neoplasms; Buprenorphine; Corticosterone; | 2007 |
Anesthetic management of whole-body hyperthermia for the treatment of cancer.
Topics: Adolescent; Adult; Aged; Anesthetics; Body Temperature; Body Temperature Regulation; Chemical and Dr | 1980 |
Withdrawal symptoms during therapy with transdermal fentanyl (fentanyl TTS)?
Topics: Administration, Cutaneous; Adult; Colonic Neoplasms; Female; Fentanyl; Humans; Middle Aged; Morphine | 1994 |
[Value of transdermal fentanyl administration in child in palliative care].
Topics: Administration, Cutaneous; Analgesics, Opioid; Brain Neoplasms; Child; Fentanyl; Humans; Male; Neopl | 1999 |